Sorbent Therapeutics Lands $36,000,000 Series B Financing
Jun 30, 2011 • Deals • TechZulu Inc.
| Company Name | Sorbent Therapeutics |
| Information Release Date | 6/30/2011 |
| Transaction Type | Venture Equity |
| Amount | $36,000,000 |
| Round | Series B |
| Proceeds Purpose | The financing will enable Sorbent to complete Phase 2 for its lead program in heart failure, CLP1001. |
